These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 593967

  • 1. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A, Ledea N, Hermández K, Garcia-Barreto D.
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C, Wang K, Zhang H.
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [Abstract] [Full Text] [Related]

  • 5. The electrophysiology of Norpace (Part I).
    Dreifus LS.
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract] [Full Text] [Related]

  • 6. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N, Carlier J.
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract] [Full Text] [Related]

  • 7. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S, Bailey JC.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
    Duchêne-Marullaz P, Lapalus P, Lavarenne J, Combre A.
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):150-8. PubMed ID: 4460907
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG, Hatley FR, McDonald SJ, Stamm MH, Garthwaite SM.
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP.
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M, Grewe N, Nissen H.
    MMW Munch Med Wochenschr; 1976 Mar 12; 118(11):331-4. PubMed ID: 57570
    [Abstract] [Full Text] [Related]

  • 20. Disopyramide phosphate: is it just another quinidine.
    Kus T, Sasyniuk BI.
    Can J Physiol Pharmacol; 1978 Apr 12; 56(2):326-31. PubMed ID: 638888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.